Tumor necrosis factor-α promoter-308 G/A polymorphism and susceptibility to sepsis in very-low-birth-weight infants

Critical Care Medicine

Volumn 39, Issue 5, 2011, Pages 1190-1195

  Härtel, Christoph ^a   Hemmelmann, Claudia ^a   Faust, Kirstin ^a   Gebauer, Corinna ^b   Hoehn, Thomas ^c   Kribs, Angela ^d   Laux, Reinhard ^g   Nikischin, Werner ^e   Segerer, Hugo ^h   Teig, Norbert ^f   Von Der Wense, Axel ⁱ   Wieg, Christian ^j   Herting, Egbert ^a   Göpel, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g Asklepios Klinikum Hamburg Barmbek   (Germany)

^h Children's Hospital St Hedwig Regensburg   (Germany)

ⁱ Altonaer Kinderkrankenhaus   (Germany)

^j Children's Hospital of Aschaffenburg   (Germany)

more..

Author keywords

sepsis; tumor necrosis factor 308 G A polymorphism; very low birth weight infants

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

BLOOD CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMANY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; VERY LOW BIRTH WEIGHT;

EID: 79955463010     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31820ead07     Document Type: Conference Paper

References (19)

1. Kumpf O, Schumann R: Genetic variation in innate immunity pathways and their poten-tial contribution to the SIRS/CARS debate: Evidence from human studies and animal models. JInnate Immunity 2010; 2:381-394
2. Wilson AG, Symons JA, McDowell TL, et al: Effects of a polymorphism in the human tu-mor necrosis factor alpha promoter on tran-scriptional activation. Proc Nat Acad Sci USA 1997; 94:3195-3199 (Pubitemid 27157287)
3. Menges T, König IR, Hossain H, et al:. Sepsis syndrome and death in trauma patients are associated with variation in the gene encod-ing tumor necrosis factor. Crit Care Med 2008; 36:1456-62, e1-e6
4. Teuffel O, Ethier MC, Beyene J, et al: Asso-ciation between tumor-necrosis factor-alpha promoter-308 A/G polymorphism and susceptibility to sepsis and sepsis mortality: A systematic review and meta-analysis. Crit Care Med 2010; 38:276-282
5. Härtel C, Schultz C, Herting E, et al: Genetic association studies in VLBW infants exempli-fying susceptibility to sepsis\Recent find-ings and implications for future research. Acta Paediatrica 2007; 96:158-165
6. Weitkamp JH, Stüber F, Bartmann P: Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis. Infection 2000; 28: 92-96 (Pubitemid 30189614)
7. Hedberg CL, Adcock K, Martin J, et al: Tu-mor necrosis factor alpha-308 polymor-phism associated with increased sepsis mor-tality in ventilated very low birth weight infants. Pediatr Infect Dis J 2004; 23:424-8 (Pubitemid 38621481)
8. Treszl, A, Kocsis I, Szathmári M, et al: Ge-netic variants ofTNF-[FC12]a, IL-1beta, IL-4 receptor [FC12]a-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003; 83:241-5 (Pubitemid 36566274)
9. Abu-Maziad A, Schaa K, Bell EF, et al: Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 2010; 68:323-329
10. Härtel C, Haase B, Carmo K, et al: Does the enteral feeding advancement effect short term outcomes in very-low-birth-weight in-fants? J Pediatr Gastroent Nutr 2009; 48: 464-470
11. Baird PN, Robman LD, Richardson AJ, et al: Gene-environment interaction in progres-sion of AMD: The CFH gene, smoking and exposure to chronic infection. Hum Mol Genet 2008; 17:1299-305 (Pubitemid 351566966)
12. Stanulla M, Schrauder A, Welte K, et al: Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of re-lapse in childhood B-cell precursor acute lymphoblastic leukemia: A case-control study of patients treated with BFM therapy. BMC Blood Disord 2001; 1:2
13. Härtel C, Rupp J, Hoegemann A, et al: 159C
14. Harding D, Dhamrait S, Millar A, et al: Is interleukin-6-174 genotype associated with the development of septicemia in preterm infants? Pediatrics 2003; 112:800-803 (Pubitemid 37248686)
15. Chauhan M, McGuire W: Interleukin-6 (-174C) polymorphism and the risk of sepsis in very low birth weight infants: meta-analysis. Arch Dis Child Fetal Neonatal Ed 2008; 93: F427-F249
16. Deasy A, Read RC: Genetic variation in pro-inflammatory cytokines and meningococcal sepsis. Curr Opin Infect Dis 2010; 23:255-258
17. Ferwerda B, Alonso S, Banahan K, et al: Func-tional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by provid-ing protection against septic shock Proc Nat AcadSciUSA 2009; 106:10272-7
18. Zhang S, Wang C, Xi B, et al: Association between the tumour necrosis factor-a-308G/A polymorphism and chronic obstruc-tive pulmonary disease: An update. Respirol-ogy 2010 Oct 14 [Epub ahead ofprint]
19. Bizzarro MJ, Jiang Y, Hussain N, et al: The impact of environmental and genetic factors on neonatal late-onset sepsis. JPediatr 2011; 158:234-238